Literature DB >> 15994616

Prospective data collection of a new procedure by a specialty society: the FIBROID registry.

Evan R Myers1, Scott Goodwin, Wendy Landow, Matthew Mauro, Eric Peterson, Gaylene Pron, James B Spies, Robert Worthington-Kirsch.   

Abstract

OBJECTIVE: To describe registry methods and baseline patient demographics from a national sample of women undergoing uterine artery embolization for uterine leiomyomata.
METHODS: Interventional radiology practices were recruited to submit data by a secure Web site on women undergoing uterine artery embolization for symptomatic leiomyomata. Baseline data included patient demographics, prior medical, surgical, and obstetrical history, uterine anatomy, and quality-of-life measures. Subsequent data collected included details of the uterine artery embolization procedure and hospital stay and outcomes at 30 days; patients were also offered the opportunity to participate in longer-term follow-up. Characteristics of white and African-American women were compared using t tests, chi(2), or Wilcoxon rank-sum tests as appropriate.
RESULTS: As of December 31, 2002, 3,319 uterine artery embolization cases had been entered into the registry by 72 sites; number of patients entered by individual sites ranged from 1 to 514. Of these patients, 95.4% consented to participation in the short-term outcomes registry. Forty-eight percent of patients were African American, and 44.4% were white and non-Hispanic. Heavy menstrual bleeding was the single most bothersome symptom in 64.3% of patients. Compared with white non-Hispanic women, African-American women were significantly younger, more likely to be obese, had larger uteri and more numerous leiomyomata, more severe symptoms, and poorer quality-of-life scores before treatment.
CONCLUSION: It is feasible to collect prospective data on new technologies. The FIBROID Registry prospectively collected data on more than 3,000 women undergoing uterine artery embolization for symptomatic leiomyomata. Baseline patient characteristics of this patient population seem to be similar to those of women undergoing other procedures for leiomyomata. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2005        PMID: 15994616     DOI: 10.1097/01.AOG.0000165827.66541.dd

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Disparities in use of laparoscopic hysterectomies: a nationwide analysis.

Authors:  Pooja R Patel; Jinhyung Lee; Ana M Rodriguez; Mostafa A Borahay; Russell R Snyder; Gary D Hankins; Gokhan S Kilic
Journal:  J Minim Invasive Gynecol       Date:  2013-09-04       Impact factor: 4.137

Review 2.  Current evidence on uterine embolization for fibroids.

Authors:  James B Spies
Journal:  Semin Intervent Radiol       Date:  2013-12       Impact factor: 1.513

3.  Cellular kinetics of MED12-mutant uterine leiomyoma growth and regression in vivo.

Authors:  Vanida A Serna; Xin Wu; Wenan Qiang; Justin Thomas; Michael L Blumenfeld; Takeshi Kurita
Journal:  Endocr Relat Cancer       Date:  2018-04-26       Impact factor: 5.678

4.  Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010.

Authors:  Jinhyung Lee; Kristofer Jennings; Mostafa A Borahay; Ana M Rodriguez; Gokhan S Kilic; Russell R Snyder; Pooja R Patel
Journal:  J Minim Invasive Gynecol       Date:  2014-01-24       Impact factor: 4.137

5.  Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy.

Authors:  Patricia G Moorman; Phyllis Leppert; Evan R Myers; Frances Wang
Journal:  Fertil Steril       Date:  2012-11-27       Impact factor: 7.329

6.  MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials.

Authors:  Ronit Machtinger; Fiona M Fennessy; Elizabeth A Stewart; Stacey A Missmer; Katharine F Correia; Clare Mc Tempany
Journal:  J Ther Ultrasound       Date:  2013-12-02

7.  A Patient Registry for the Management of Uterine Fibroids in Canada: Protocol for a Multicenter, Prospective, Noninterventional Study.

Authors:  Mohamed A Bedaiwy; Peter Janiszewski; Sukhbir S Singh
Journal:  JMIR Res Protoc       Date:  2018-11-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.